ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2016 065 022.3, EP file number: 16 92 3536.3, WO file number: PCT/CN2016/109564 (Designation/title: 8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-PROPANSÄUREMETHYLESTER (REMIMAZOLAM, CNS 7056) HYDROBROMIDE (1:1) SALZ ZUR INJEKTION FÜR SEDIERUNG UND ANÄSTHESIE)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Jun 14, 2018Jun 14, 2018 unchanged
2 Q10 Document published Oct 16, 2019Oct 16, 2019 Filing
3 Q10 Document published Nov 28, 2019Nov 28, 2019Nov 28, 2019 Filing
4 Q10 Document published Oct 13, 2021Oct 13, 2021 Examination
5 Q10 Document published Nov 4, 2021Nov 4, 2021Nov 4, 2021 Examination
6 F10 IP right granted Jul 14, 2022Jul 14, 2022Oct 6, 2022 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Jun 14, 2018Jun 14, 2018 unchanged
2 Q12 Application published Oct 16, 2019Oct 16, 2019 Filing
3 Q10 Document published Nov 28, 2019Nov 28, 2019Nov 28, 2019 Filing
4 P22 Classification modified Mar 30, 2021Mar 30, 2021 Filing
5 Q10 Document published Oct 13, 2021Oct 13, 2021 Examination
6 Q10 Document published Nov 4, 2021Nov 4, 2021Nov 4, 2021 Examination
7 F10 IP right granted Jul 14, 2022Jul 14, 2022Oct 6, 2022 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data